The messenger RNA expression levels of the (A) ACAT1, (B) SREBP-2, (C) HMGCR, (D) SQLE, (E) LXR, (F) CYP7A1, (G) LDLR, (H) PCSK9, (I) SR-B1, and (J) ABCA1 genes were analyzed by quantitative real-time polymerase chain reaction and normalized to that of the ACTB gene
5-amino-1-methylquinolinium (5-amino-1MQ) represents a significant advancement in the field of metabolic research, emerging as a potent, selective inhibitor of nicotinamide N-methyltransferase (NNMT)
The information contained herein is for informational purposes only and does not establish a doctor-patient relationship.
10.1016/S0074-7742(07)82016-2 Int Rev Neurobiol
In a rat model of ischemic stroke after middle cerebral artery occlusion (MCAO), IN DFO significantly reduced infarct volume and neurological deficits (Hanson et al., 2009)
Consult your healthcare provider for personalized guidance.